No abstract available
MeSH terms
-
Abciximab
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use
-
Coronary Disease / drug therapy*
-
Drug Monitoring
-
Eptifibatide
-
Female
-
Humans
-
Immunoglobulin Fab Fragments / adverse effects
-
Immunoglobulin Fab Fragments / therapeutic use
-
Incidence
-
Male
-
Peptides / adverse effects
-
Peptides / therapeutic use
-
Platelet Aggregation Inhibitors / adverse effects*
-
Platelet Aggregation Inhibitors / therapeutic use*
-
Prognosis
-
Risk Assessment
-
Thrombocytopenia / chemically induced*
-
Thrombocytopenia / epidemiology
-
Tirofiban
-
Tyrosine / adverse effects
-
Tyrosine / analogs & derivatives
-
Tyrosine / therapeutic use
Substances
-
Antibodies, Monoclonal
-
Immunoglobulin Fab Fragments
-
Peptides
-
Platelet Aggregation Inhibitors
-
Tyrosine
-
Tirofiban
-
Eptifibatide
-
Abciximab